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In recent years, an increasing number of stimulant drugs and new psychoactive substances (NPSs) have
caused concern in scientiﬁc communities and therefore innovative methods to extract compounds from
complex biological samples are required. This work is aimed at developing and validating a clean,
convenient and straightforward extraction procedure with microliter amounts of organic solvent using
Solid Phase Micro-Extraction tips (SPME tips) and analysis using Gas Chromatography-Mass
Spectrometry (GC-MS) in human urine samples. Another aim is to evaluate three diﬀerent types of SPME
ﬁbre tips C18, C18-SCX (mixed mode) and PDMS-DVB. The quantiﬁcation method examined the
diﬀerent classes of stimulant compounds included Amphetamine-Type Stimulants (ATSs) (amphetamine,
methamphetamine, para-methoxyamphetamine (PMA), and ()-3,4-methylenedioxymethamphetamine
(MDMA)) and synthetic cathinones (mephedrone, buphedrine (buphedrone ephedrine metabolite), 4-
methylephedrine (mephedrone metabolite), and pentylone). The method was developed with respect to
several areas of the experimental design including pH, ionic strength, addition of salts, vial dimensions,
analytes and derivatisation, type of solvents, solvent volume, extraction and desorption time, agitation
speeds in the extraction and desorption steps and matrix volume. The optimised method was validated
for eight compounds using the SPME PDMS/DVB ﬁbre tips with satisfactory linearity and selectivity
ranging between 50 and 2000 ng mL1, and limits of detection (LODs) and low limits of quantiﬁcation
(LLOQs) ranging between (5–25) and (25–100) ng mL1 respectively. Within-run and between-run
accuracy and precision were <15%. The method was applied to real human urine samples indicating its
suitability for common stimulant drugs and provided clean chromatograms with no interfering peaks.
The assessment of green analytical chemistry for the method used was discussed and compared with
Solid Phase Extraction (SPE). According to the results obtained we recommend the method for use in
routine laboratories carrying out drug/forensic analysis for conﬁrmation tests of the studied compounds.Introduction
Over the past few years, approximately one compound has
entered the recreational drug market on a weekly basis within the
category of new psychoactive substances (NPSs). These are syn-
thesised to bypass regulations and laws, and to have similar or
stronger eﬀects than existing drugs. Throughout the world,
amphetamine-type stimulants (ATSs) are the second most
commonly used drugs and oen exceed heroin and cocaine use.1–3
Synthetic cathinones covered approximately 23% of the
global trends of individual NPSs reported in the Early Warningedicine, Dentistry and Nursing, College of
rsity of Glasgow, Glasgow, G12 8QQ, UK.
edicine, Dentistry and Nursing, College of
rsity of Glasgow, Glasgow, G12 8QQ, UK.
Chemistry 2018Advisory (EWA) from 2008 to 2015.3 Cathinone is found in the
plant Catha edulis (khat) and synthesized derivatives have
a varied range of b-ketoamphetamines and have been sold as
alternatives to ATSs. Fatalities and toxicity related to the abuse
of stimulant drugs and synthetic cathinones are of international
concern with several deaths reported.4–11
Consequently, the proof of identity of ATSs and synthetic
cathinones in biological specimens is vital in the clinical,
forensic and toxicology elds since most of the NPSs are not
fully detected using routine immunoassay screening methods.
This may be a result of cost-ineﬀectiveness or unavailability of
reagents. Moreover, the conrmation of positive results in
chromatographic and mass spectrometric techniques is
required for accurate molecule identication and to distinguish
between isomers and structures.
Biological samples contain various components with urine and
blood which are not compatible with complex instrumentation.Anal. Methods
Analytical Methods Paper
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View Article OnlineThis can be solved by using a sample preparation technique
which eliminates some components in biological samples and
keeps the analytes of interest. Therefore, the requirement for
a fast, clean and convenient procedure to reduce instrument
contamination plays an essential role in any laboratory.
Solid Phase Micro-Extraction (SPME) was used for the rst time
in 1989 by Pawliszyn and his colleagues.12 It was carried out to
minimise the time taken for the sample preparation and reduce
the amount of both solvents and samples on themicro-liter scale.12
SPME is easy to employ, allows rapid screening with minimum
contact with toxic solvents, and can be bothmanual or automated.
It is a sensitive, eﬃcient technique and reduces the time required
and cost. It is highly eﬃcient for screening purposes due to its
speed and ease of use. The problem of sample loss, contamination
and dilution can be avoided by the use of this technique.13
GC-MS is the most common technique in clinical toxicology
and forensic laboratories and is more economical than LC-MS-
MS, and therefore methods developed using GC-MS have an
extensive range of applicability in forensic toxicology laboratories.
The aims of this work were:
 To develop and validate a clean and convenient method on
amicroliter scale using SPME tips and GC-MS for the analysis of
8 stimulant drugs including ATSs and synthetic cathinones in
urine, and the compounds studied are shown in Table 1.
 To evaluate the new biocompatible SPME LC tips con-
taining bres of C18, C18/SCX and PDMS/DVB.
 To reduce the environmental and health impacts
compared to traditional sample preparation methods such as
solid phase extraction (SPE).
 To address the need for green analytical chemistry.
 To evaluate this method when it is applied for real human
urine samples.Materials and methods
Materials
The reference standards of amphetamine, methamphetamine,
PMA, MDMA, cathinone, mephedrone, buphedrine, 4-methyl-
ephedrine, and pentylone, three internal standards (ISDs) –Table 1 Chemical structures
Anal. Methodsamphetamine-d11 (1 mg mL1), cathinone d5 (0.1 mg mL1) and
pentylone-d3 (0.1 mg mL1) as hydrochloride salts, pentauoro-
propionic anhydride (PFPA), formic acid (FA), three types of
SPME ber tips: PDMS-DVB, C18 and C18-SCX silica, vial kits of
two sizes, 0.3 mL and 1.2 mL, natural PTFE/silicone septa (with
slit), and thread 9 mm were purchased from Sigma-Aldrich,
Gillingham, UK. The SPME bre tips with stationary phase
C18-SCX were kindly donated by Sigma Aldrich.
Methanol (MeOH), acetonitrile, ethyl acetate (EtOAc),
acetone, 2-propanol, ammonium hydroxide (NH4OH), sodium
phosphate dibasic, sodium chloride, sodium phosphate mono-
basic, dichloromethane (DCM), isopropanol (IPA), hydrogen
chloride (HCl), acetic acid, sodium hydroxide (NaOH), sodium
chloride (NaCl) and microcentrifuge Eppendorf tubes 1.5 mL
were obtained from VWR International, East Grinstead, UK.
Phosphate buﬀer and sodium phosphate were purchased
from Fisher Scientic, Loughborough, UK. 200 mg solid phase
extraction (SPE) clean screen extraction columns, United
Chemical Technologies (UCT), part number ZSDAU20, were
purchased from Chromatography Direct, Runcorn, UK.
Deionised water was generated from an ultrapure water
purication system (Merck Direct QR 3UV water deionizer).Ethics statement
Written informed consent was obtained from all subjects. The
protocol was reviewed and approved by the MVLS College Ethics
Committee, University of Glasgow (200160055) and the
Research Committee at Security Forces Hospital, Riyadh, Saudi
Arabia (16-190-24).
Drug-Free Urine (DFU) specimens were collected from
volunteers and conrmed negative for the target analytes. The
protocol was reviewed and approved by the MVLS College Ethics
Committee, University of Glasgow (200160020).Methods
Preparation of standards
Stock solutions (100 mg mL1) of the eight drugs, listed in Table
1, were prepared by the dilution of purchased standards viaThis journal is © The Royal Society of Chemistry 2018
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View Article Online1 : 10 dilution inmethanol. A mixture of the working solution of
each standard was prepared by the dilution of the 100 mg mL1
stock solutions via 1 : 50 dilution in Drug-Free Urine (DFU) to
reach a concentration of 2 mg mL1.
Working internal standards (ISDs) of the deuterated stan-
dards were prepared by the dilution of purchased internal
standards via 1 : 10 dilution in methanol to reach 10 mg mL1.
The mixture of the 8 drugs in urine and ISDs were stored at
20 C until use.Optimised procedure
The optimised procedure was applied to assess the parameters
of the method validation work.
Initially, the SPME tips (PDMS-DVB bre) were conditioned
between 10 and 20 minutes in MeOH : distilled water (50 : 50).
1 mL of the drug mixture in urine (for example 2 mg mL1)
and 100 mL of ISDs of amphetamine d11 and pentylone d5
(1 mg mL1) with 0.5 g NaCl and 100 mL of 10% NaOH (pH 12.6)
were added to 1.5 mL microcentrifuge Eppendorf tubes. The
Eppendorf tubes were pierced before inserting the SPME tips.
The samples including tips were placed in a shaker (IKA
VIBRAX VXR) for agitation at a speed of 2000 rpm. They were le
for at least 1 hour so that equilibrium between the analytes and
stationary phase was reached.
The SPME tips were transferred to 0.3 mL vials with the
addition of 65 mL of MeOH and le for 10 minutes at an
agitation speed of 2000 rpm. 10 mL of acidied methanol (1 : 9)
was added, and the vials were evaporated under a stream of
nitrogen at room temperature (RT) until fully dry.
The vials were then derivatised by adding 50 mL PFPA and
EtOAc (2 : 1). The samples were capped and vortexed immedi-
ately for 3–5 seconds and then incubated for 10–15 minutes at
60 C. The samples were evaporated under a stream of nitrogen
at RT. The time required until fully dried in the evaporation
steps was 2–5 minutes only. The samples were reconstituted in
50 mL of ethyl acetate before 1 mL was injected into the GCMS for
analysis (see Fig. 1).Fig. 1 Illustration of the optimum condition procedure applied to SPME
This journal is © The Royal Society of Chemistry 2018Method development preparation
The method development of SPME tips was assessed based on
the following criteria: the pH of buﬀer, ionic strength, addition
of salts, size of vials, analyte and derivatisation, type of solvents,
solvent volume, extraction time, agitation speed in the extrac-
tion step, desorption time, agitation speed in the desorption
step andmatrix volume. Each criterion was evaluated as a single
factor keeping the other factors constant.
The parameters were assessed based on the absolute
recovery14 by adding 1 mL urine containing the mixture of the 8
drugs (1 mg mL1). A 50 mL ISD (0.5 mg mL1) of amphetamine
d11 was added prior to the evaporation step.
100 mL of a duplicate unextracted mixture of the 8 drug
samples (1 mg mL1) and a 50 mL ISD of amphetamine d11
(0.5 mg mL1) were added on each evaluation day.
The response of extracted (response of extracted analyte 
response of ISD)/response of unextracted (response of unex-
tracted analyte  response of ISD) ratio (%) is calculated as the
recovery rate on each day of the method development process.
The pH buﬀering of urine was evaluated on the three bres
and adjusted to pH 3, 5, 7, 9 and 11 by adding small drops of
formic acid, HCl for acidity products, 25% NaOH for alkaline
products and phosphate buﬀer for pH 7.
The ionic strength and the additive of NaOH and KOH salts
(5%, 10% and 25% (w/v)) with and without NaCl (0.1, 0.25, 0.5,
0.75 and 1 g; 5%, 10% and 25% (w/v)) were examined in
duplicate samples. The experiments were repeated three times
on three diﬀerent days for NaOH (5%, 10% and 25%) with NaCl
(0.1, 0.25, 0.5, 0.75 and 1 g) to conrm the results.
The evaluation of the sample volume was performed in
triplicate vials at volumes of 1000, 500 and 100 mL at a concen-
tration of 1 mg mL1.
The derivatisation agent was evaluated by the application of
the duplicate samples of PFPA derivatives added pre-, during
and post-extraction and aer the rst evaporation step.
The solvents MeOH, acetonitrile, EtOAc, (NH4OH : MeOH;
2 : 98), (NH4OH : MeOH; 0.5 : 99.5), (DCM : IPA : NaOH4;PDMS/DVB ﬁbre tips in the mixture of drugs in urine samples.
Anal. Methods
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View Article Online78 : 20 : 2), IPA and (acetone : water; 20 : 80) were evaluated in
triplicate samples on two days.
The triplicate samples at extraction times of 15, 30, 45, 60, 90
and 120 min with agitation speeds of 500, 1000, 1500 and
2000 rpm were evaluated on two days.
The triplicate samples in the desorption step at times of 15,
30, 45, 60 and 90 min with agitation speeds of 500, 1000, 1500
and 2000 rpm were assessed. The triplicate samples in the
desorption step were evaluated again at times of 20, 30, 40 and
50 min with agitation speeds of 1500 and 2000 rpm. The trip-
licate samples in the desorption step were evaluated once more
at times of 1, 5, 10 and 20min at an agitation speed of 2000 rpm.
The evaluation of two types of vials, Eppendorf vials (1.5 mL)
and kit vials (1.2 mL), was performed by applying the optimum
procedure in duplicate samples. They were examined oncemore
to evaluate the linearity at concentrations of 50, 100, 250, 500,
750, 1000, and 2000 ng mL1 (duplicate samples at each point).
All the developed method parameters were tested in the spiked
urine containing the 8 stimulant drugs at a concentration of
1 mg mL1.Method validation
The method was validated through evaluating the method
validation parameters based on the Scientic Working Group
for Forensic Toxicology (SWGTOX, 2012) guidelines: linearity,
limit of detection (LOD), lower limit of quantitation (LLOQ),
accuracy, precision, selectivity, interference and carryover.
The linearity study was performed for each substance by
spiking 1 mL of drug-free urine (DFU) with the mixture of
standards to obtain the concentrations of 50, 100, 250, 500, 750,
1000, and 2000 ng mL1. Calibration curves for the mixtures in
urine were plotted by the linearity method to calculate the linear
regression (R2) of the area ratio of each compound with the ISDs
versus the concentration of the analyte. It was assessed by
analysing 20 separate calibration curves on ve consecutive
days. The accuracy of each point was calculated in the linearity
study and should not exceed 20%.
The limit of detection (LOD) and the lower limit of quantita-
tion (LLOQ) were dened as a signal-to-noise (S/N) ratio
exceeding three and ten respectively which were assessed for at
least three ions of each substance. The assessment of the
mixtures of the urine samples was repeated for each concentra-
tion ten times at concentrations of 200, 100, 50, 25, 10, 5, and
1 ng mL1. The LLOQ parameter was assessed once more by
calculating the lowest concentration at which the analyte could
be quantied (relative standard deviation (RSD) and bias# 20%).
The accuracy and precision of the method were determined
by the analysis of four replicate samples at three quality controls
(QC): QC1 ¼ 250, QC2 ¼ 850 and QC3 ¼ 1500 ng mL1 on the
same days of the linearity study. Within-run and between-run
accuracy and precision were determined for each analyte with
the maximum of RSD and bias values not exceeding 15%.
The interference study was performed by analysing ten
diﬀerent individual blank urine samples for verifying the
absence of the peaks interfering with the analytes of interest via
SIM mode.Anal. MethodsThe selectivity of the method was assessed by running tripli-
cate mixture samples of 22 similar drugs cathinone, methcathi-
none, ephedrone, 4-methyl-N-ethyl-norephedrine (4-MEC
metabolite), bupherone, N-ethylecathinone, para-methox-
yamphetamine (PMA), pentedrone, methedrone, methylone,
butylone, ethylone, pyrovalerone, 3,4-methylenedioxyamphet-
amine (MDA), para-methoxy-N-methylamphetamine (PMMA), 4-
ethylmethylcathinone (4-EMC), methedrone, ()-N-ethyl-3,4-
methylenedioxyamphetamine (MDEA), a-pyrrolidinovaler-
ophenone (a-PVP), 30,40-methylenedioxy-a-pyrrolidinopropio-
phenone (MDPPP), naphyrone, andmethylenedioxypyrovalerone
(MDPV) at a concentration of 2 mg mL1 spiked with DFU.
Carryover eﬀects were checked by analysing blank urine
specimens aer the injection of the highest point of the
calibrator.
All method validation parameters were obtained by applying
the optimised procedure mentioned above (see the Optimised
procedure section; Fig. 1).Application to real urine samples
The method was applied to three urine samples collected from
Saudi Arabia that were conrmed positive for cathinone when
previously analysed with a valid solid phase extraction method
(SPE). The SPE method was validated in our laboratory for the
determination of 20 stimulant drugs based on GC-mass
spectrometry.Fragmentation criteria
The criteria for the identication of the mixture compounds
were the retention time (tR) with the presence of at least three
fragmentation ions and their relative ion intensities%. For the
identication of an analyte, tR should not vary more than 1%;
relative ion intensities should not exceed more than 10% for
ions with relative intensities > 50%.GC-MS methodology
The method was carried out with Gas Chromatography-Mass
Spectrometry (GC-MS) using a 7890A GC/5975C MSD, a split/
splitless inlet and a DB-5ms (5% phenyl/95% methylpolysilox-
ane; 30 m  0.25 mm, 0.25 mm lm thickness) separation
column (all from Agilent Technologies, Waldbronn, Germany).
Helium was used as a carrier gas (99.99% purity). Splitless
injection at 225 C was employed. The column temperature
programme was initially started at 70 C and then raised to
200 C at a rate of 11 C min1 (held for 4 minutes), and 200 C
to 280 C at a rate of 10 C min1 (held for 1 minute). The total
time was 25minutes. TheMS transfer line temperature was kept
at 250 C. The MS was operated in the electron impact ionisa-
tion mode (70 eV). The ion source was maintained at 200 C. MS
data acquisition was initiated at 7 minutes and was performed
in the selected ion monitoring (SIM) mode. The method was
developed to provide an excellent separation and response. All
data acquisition and processing steps were performed using
GC/MSD ChemStation Soware Version 6.5.This journal is © The Royal Society of Chemistry 2018
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View Article OnlineResults and discussion
SPME tip extraction and GC-MS methods
GC MS was initially developed until the desired responses were
achieved along with separation and detection by applying the
mixture of the 8 stimulant drugs. Each standard of the mixture
compounds was prepared alone by running unextracted
samples with PFPA derivatives. The separation, tR and frag-
mentation patterns with the ion intensity ratio% were consid-
ered and recorded. The random procedure of SPME tips was
initially applied to the optimised conditions of the GC MS. The
responses of the SMPE tips were compared with unextractedTable 2 SIM fragmentation patterns (m/z) and relative ion intensities
remaining ions were used as qualiﬁer ions with the ratio (%)
Target compounds tR m/z Ratio (%
Amphetamine d11 8.422 194 100
128 72
98 33
Amphetamine 8.486 190 100
118 79
91 36
65 9
Methamphetamine 9.505 204 100
160 31
118 24
91 14
Pentylone d5 16.339 193 100
235 86
148 380
Buphedrine (buphedrone metabolite) 9.770 218 100
119 12
308 3
160 18
Fig. 2 (A) SIM chromatogram for the eight stimulant drugs (SPME tips and
of 1 mg mL1 in a urine sample. (B) Chromatogram (SIM) for a blank urin
This journal is © The Royal Society of Chemistry 2018sample responses (ISD was involved in the calculation). This
process showed an initial successful separation and detection
in the chromatogram through the procedure of SPME tips (see
Fig. 2 and Table 2).Method development
The presence of an eﬃcient, convenient, clean and reliable
method for the sample preparation of stimulant drugs such as
ATSs and synthetic cathinones and other related compounds of
NPSs is important in forensic toxicology laboratories, speci-
cally for conrmation tests. The nal products of the method
development processes enabled the detection of ATSs and(ratio%) with the retention time (tR). Quantiﬁcation ions in bold. The
) Target compounds tR m/z Ratio (%)
4-Methylephedrine
(mephedrone metabolite)
10.158 204 100
119 13
160 20
308 3
PMA 10.854 121 100
148 42
190 5
311 7
Mephedrone 11.215 119 100
204 25
91 20
160 14
MDMA 13.315 204 100
162 73
135 43
339 12
Pentylone 16.442 149 100
190 22
232 19
381 5
PFPA derivative; optimum conditions were applied) at a concentration
e sample.
Anal. Methods
Analytical Methods Paper
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View Article Onlinecathinones to provide excellent repeatability and reproducibility
using only microliter quantities of organic solvent (50 mL of
MeOH). The advantage of using SPME PDMS/DVB bre tips is
that the equilibrium between the analyte and the stationary
phase occurs in only one step. This provides safety and less
handling of the operators. Furthermore, it benets the envi-
ronment and economy with less consumption of vials, solvents
and chemicals making this procedure favourable.
Two types of vials were used in the procedure, the rst one
(1.5 mL Eppendorf vial) was used for the sample preparation
and extraction steps. The second vial (0.3 mL kit vial) was used
in the following stages: the desorption, evaporation, derivati-
sation and GC-MS stages. The extraction prociency proved the
validity of the method to extract and quantify the target analytes
even at low sample volumes and concentrations. The total time
required for the sample preparation process until running the
samples was 2–3 hours (as an average of preparing 20–30
samples). The conditions of gas chromatography were adjusted
to provide an excellent peak shape and responses which allowFig. 3 An example of the developed method results for some compoun
salts (B); in SPME PDMS/DVB ﬁbre tips (duplicate samples of the drug m
Table 3 Summary of the optimum conditions of the method develop
signiﬁcant recovery% of the 8 stimulant drugs at a concentration of 1 mg
calculation of RSD and bias in each parameter
Parameters versus ber type PDMS/DVB
Salts NaOH + NaCl
Ionic strength (v/w) 10% NaOH + 0.5 g NaCl (pH 12.6)
pH $11, the greatest recovery results
were at pH 12.6
Sample volume 1 mL
Derivatisation agent (PFPA) When the PFPA was added aer the
evaporation step
Extraction time $1 hour
Extraction speed 2000 rpm
Desorption type MeOH, acetonitrile and DCM: ISO:
NaOH4
Desorption time 10 min
Desorption speed 2000 rpm
Linearity 0.992–999
Recovery 2–80%
Vial type Both Eppendorf vials and kit vials
were valid
Anal. Methodsthe separation of the 8 stimulant substances in 25 minutes by
using PFPA derivatives. In addition, the conditions of chroma-
tography also permitted the separation of two metabolites in
urine (buphedrone ephedrine metabolite and mephedrone
metabolite).
GC MS is commonly used in the majority of laboratories and
is attractive in terms of nancial sustainability.
The method was applied to the collected urine samples to
demonstrate the validity of the technique for application as
a conrmation method in forensic toxicology analysis.
The main aims of the method development were:
◦ To reach the highest equilibrium between the analyte and
stationary phase in SPME tips.
◦ To obtain the highest recovery%.
◦ To assess the three diﬀerent bre tips.
◦ To validate the SPME tips for the quantication of the 8
compounds in urine using GC MS.
The extraction products can be optimised by altering the
sample conditions.15 Therefore, several parameters ofds examined showing the eﬀect of buﬀering pH (A) and the additive of
ixture at a concentration of 1 mg mL1 in urine).
ment parameters. The outcome was concluded based on the most
mL1 in urine. Invalid (mentioned in the table) was concluded after the
C18 Mixed mode
Formic acid Formic acid + HCL
100 mL formic acid 100 mL pH 3 FA + 100 mL 0.1 HCL
pH 2.8 pH 3.3
Invalid Invalid
Aer the evaporation step Aer the evaporation step
Invalid Invalid
Invalid Invalid
Invalid Invalid
Invalid Invalid
Invalid Invalid
Invalid Invalid
0.1–10% 0.1–10%
Invalid Invalid
This journal is © The Royal Society of Chemistry 2018
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View Article Onlineexperimental design were considered in the process of the
method development (the pH of buﬀer, ionic strength, addition
of salts, size of vials, analyte and derivatisation, type of solvent,
solvent volume, extraction time, agitation speed in the extrac-
tion step, desorption time, agitation speed in the desorption
step and matrix volume). The work was carried out to study
three diﬀerent bre tips (C18, C18-SCX and PDMS/DVB) via
method development processes. The stationary phase of PDMS/
DVB bre tips provided the maximum recovery (2–80%)
compared to C18 (0.1–10%) and C18-SCX (0.1–10%). The
recovery was calculated through all the method development
parameter processes.
The results of the developed method are summarised in
Table 3. In summary, the PDMS/DVB bre tips proved to reach
the maximum equilibrium in the reaction for all stimulant
drugs tested. An example of pH buﬀering results and addition
of salts is shown in Fig. 3.ra
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5%Green analytical chemistry
The assessment of green analytical chemistry is complex and
has several criteria and variations that need to be checked. In
many cases it is diﬃcult to meet the ideal green analytical
methodology in the procedure, because method validation is
diﬃcult to achieve without the use of hazardous substances. In
our procedure, we minimise the use of solvents, chemicals and
reagents to meet the lowest eﬀects or hazards with the consid-
eration of the criteria of assessment and method validation.
The ve criteria for the evaluation of green analytical
chemistry are health, safety, environment, energy and waste.
Based on the above criteria, we compared the SPME tip proce-
dure with the SPE method16 in the stage of sample preparation
only, i.e. when they were applied for ATSs and synthetic cath-
inone compounds. Both extraction methods have similar
compounds that meet the requirements of method valida-
tion.17–19 The tool of assessment was recently discussed in
a paper by Płotka-Wasylka.20 For the results and overall
discussion see Table 4.T
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The results for all obtained validation parameters were
successful for the observed analytes.
The method was linear demonstrated by R2 which was
always higher than 0.992 in the range of the LLOQ (at least
$100 ng mL1) for all compounds of interest.
The LODs ranged from 5 to 25 ng mL1 for all the drugs
investigated.
The LLOQ ranged from 25 to 100 ng mL1 for all the
substances tested.
Both the within and between run precision and accuracy
were satisfactory with results in an acceptable range giving
values lower than 15%.
No carryover was recognised for any of the stimulant analy-
tes. No peak was observed from endogenous urine compounds
in the blank for the interference study or from the 20 drugs
tested in the selectivity study that aﬀected the interpretationAnal. Methods This journal is © The Royal Society of Chemistry 2018
Table 6 The comparison of the results of three positives of cathinone in urine specimens when it's applied to SPE and SPME tips in GC MS (the
urine samples were collected from real human cases in Saudi Arabia under the approval of the ethics committee). The unit of concentration is
ng mL1. The results were obtained after plotting great linearity and QCs. The average of the concentration of triplicate samples was applied to
each sample
Serial &
extraction method type
The average conc. for the
validated method of SPE with SD
The average conc. for the new trends of
SPME PDMS/DVB bre tips with SD
Sample number 1 802  32 806  76
Sample number 2 1209  47 1201  98
Sample number 3 227  30 285  51
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View Article Onlineresults in SIM mode. The outcome data to evaluate the method
validation parameters are presented in Table 5.
The SPME PDMS/DVB ber tip method was applied to real
human samples (three cases) to conrm three positives of
cathinone. The conrmation results of SPME tips were
compared with the conrmation results of the validated SPE
method. The positive results obtained from the case samples
prove the ability of the method for the quantication and
qualication of similar drugs such as cathinone compounds.
The repeatability and reproducibility of the method with
excellent selectivity and sensitivity were successfully demon-
strated in the detection of the specimens. See Table 6 for the
results.Conclusion
A clean, expedient, reliable and less costly procedure was devel-
oped and validated using urine samples for the determination of
ATSs and cathinone groups. The method used minimum solvent
to meet the requirements of green analytical chemistry with the
evaluation of two procedures in the sample preparation stage.
The nal method included SPME bre tips (PDMS/DVB) with
a PFPA derivative providing an eﬃcient extraction procedure
followed by GC-MS analysis. The SPME bre tip (PDMS/DVB)
method can be used for the conrmation of eight substances
with excellent repeatability and reproducibility. The sensitivity
and selectivity of the technique were established for the deter-
mination and detection of the compounds concerned. The limits
of quantitation were suﬃcient to quantify the positive of
amphetamine, methamphetamine, PMA, MDMA, mephedrone,
buphedrine, 4-methylephedrine and pentylone. The developed
procedure delivers only one system to conrm the eight stimu-
lant compounds including ATSs and designer cathinones in
human urine specimens. Real urine case samples were applied
for the conrmation test only. The specimens demonstrated the
validity and the suitability of the method for routine analysis of
toxicology forensic samples for the drugs mentioned and for the
conrmation test only. The applicability of GC-MS in many
laboratories worldwide enables thismethod to have the potential
for widespread use.Conﬂicts of interest
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